Have a personal or library account? Click to login
Anti-Thyroid Peroxidase/Anti-Thyroglobulin Antibody-Related Neurologic Disorder Responsive to Steroids Presenting with Pure Acute Onset Chorea Cover

Anti-Thyroid Peroxidase/Anti-Thyroglobulin Antibody-Related Neurologic Disorder Responsive to Steroids Presenting with Pure Acute Onset Chorea

Open Access
|Jul 2020

References

  1. 1Stathatos N, Daniels GH. Autoimmune thyroid disease. Current opinion in rheumatology. 2012; 24: 7075. DOI: 10.1097/BOR.0b013e32834ddb27
  2. 2Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmunity reviews. 2015; 14: 174180. DOI: 10.1016/j.autrev.2014.10.016
  3. 3Meena A, Nagar P. Pregnancy Outcome in Euthyroid Women with Anti-Thyroid Peroxidase Antibodies. Journal of obstetrics and gynaecology of India. 2016; 66: 160165. DOI: 10.1007/s13224-014-0657-6
  4. 4Afreen E, Humayun M, Sheikh A. Neurological spectrum of diseases associated with autoimmune thyroid disease: a case series to recognize diagnostically helpful signs. (P1.347). Neurology. 2018; 90: P1.347.
  5. 5Montagna G, Imperiali M, Agazzi P, et al. Hashimoto’s encephalopathy: A rare proteiform disorder. Autoimmunity reviews. 2016; 15: 466476. DOI: 10.1016/j.autrev.2016.01.014
  6. 6Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta neurologica Scandinavica. 2017; 135: 285290. DOI: 10.1111/ane.12618
  7. 7de Holanda NC, de Lima DD, Cavalcanti TB, Lucena CS, Bandeira F. Hashimoto’s encephalopathy: systematic review of the literature and an additional case. J Neuropsychiatry Clin Neurosci. 2011; 23: 384390. DOI: 10.1176/jnp.23.4.jnp384
  8. 8Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W. Hashimoto encephalopathy: a brainstem vasculitis? Neurology. 2000; 54: 769770. DOI: 10.1212/WNL.54.3.769
  9. 9Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology. 2020; 94: e217e224. DOI: 10.1212/WNL.0000000000008785
  10. 10Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Archives of neurology. 2006; 63: 197202. DOI: 10.1001/archneur.63.2.197
  11. 11Litmeier S, Prüss H, Witsch E, Witsch J. Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT. Acta neurologica Scandinavica. 2016; 134: 452457. DOI: 10.1111/ane.12556
  12. 12Mahad DJ, Staugaitis S, Ruggieri P, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci. 2005; 228: 35. DOI: 10.1016/j.jns.2004.08.015
  13. 13Ferracci F, Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol. 2006; 253: 975984. DOI: 10.1007/s00415-006-0170-7
  14. 14Termsarasab P, Pitakpatapee Y, Frucht SJ, Srivanitchapoom P. Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) Presenting with Pure Cerebellar Ataxia. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 585. DOI: 10.5334/tohm.420
  15. 15Mehta AB, Marsden CD. Latent idiopathic torsion dystonia provoked by thyrotoxicosis. J Neurol Neurosurg Psychiatry. 1981; 44: 9394. DOI: 10.1136/jnnp.44.1.93
  16. 16Javaid A, Hilton DD. Persistent chorea as a manifestation of thyrotoxicosis. Postgraduate medical journal. 1988; 64: 789790. DOI: 10.1136/pgmj.64.756.789
  17. 17Baba M, Terada A, Hishida R, Matsunaga M, Kawabe Y, Takebe K. Persistent hemichorea associated with thyrotoxicosis. Internal medicine (Tokyo, Japan). 1992; 31: 11441146. DOI: 10.2169/internalmedicine.31.1144
  18. 18Hernandez Echebarria LE, Saiz A, Graus F, et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy. Neurology. 2000; 54: 15391540. DOI: 10.1212/WNL.54.7.1539
  19. 19Taurin G, Golfier V, Pinel JF, et al. Choreic syndrome due to Hashimoto’s encephalopathy. Mov Disord. 2002; 17: 10911092. DOI: 10.1002/mds.10230
  20. 20Erickson JC, Carrasco H, Grimes JB, Jabbari B, Cannard KR. Palatal tremor and myorhythmia in Hashimoto’s encephalopathy. Neurology. 2002; 58: 504505. DOI: 10.1212/WNL.58.3.504
  21. 21Nagpal T, Pande S. Hashimoto’s encephalopathy: response to plasma exchange. Neurology India. 2004; 52: 245247.
  22. 22Loh LM, Hum AY, Teoh HL, Lim EC. Graves’ disease associated with spasmodic truncal flexion. Parkinsonism Relat Disord. 2005; 11: 117119. DOI: 10.1016/j.parkreldis.2004.08.004
  23. 23Tan EK, Chan LL. Movement disorders associated with hyperthyroidism: expanding the phenotype. Mov Disord. 2006; 21: 10541055. DOI: 10.1002/mds.20883
  24. 24Guimaraes J, Santos L, Bugalho P. Painful legs and moving toes syndrome associated with Hashimoto’s disease. European journal of neurology. 2007; 14: 343345. DOI: 10.1111/j.1468-1331.2006.01513.x
  25. 25Tan EK, Lo YL, Chan LL. Graves disease and isolated orthostatic tremor. Neurology. 2008; 70: 14971498. DOI: 10.1212/01.wnl.0000310405.36026.92
  26. 26Ku CR, Park HJ, Hong SJ, et al. A Case of Graves’ Disease Presenting with Chorea. J Korean Endocr Soc. 2008; 23: 342346. DOI: 10.3803/jkes.2008.23.5.342
  27. 27Yu JH, Weng YM. Acute chorea as a presentation of Graves disease: case report and review. The American journal of emergency medicine. 2009; 27: 369.e361–369.e363. DOI: 10.1016/j.ajem.2008.05.031
  28. 28Broch L, Amthor KF. A 66-year-old woman with confusion, aphasia, and myoclonus. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2010; 130: 10411043. DOI: 10.4045/tidsskr.09.0697
  29. 29Salazar R, Mehta C, Zaher N, Miller D. Opsoclonus as a manifestation of Hashimoto’s encephalopathy. J Clin Neurosci. 2012; 19: 14651466. DOI: 10.1016/j.jocn.2012.02.012
  30. 30Liu MY, Zhang SQ, Hao Y, Zheng HM. Paroxysmal kinesigenic dyskinesia as the initial symptom of Hashimoto encephalopathy. CNS neuroscience & therapeutics. 2012; 18: 271273. DOI: 10.1111/j.1755-5949.2012.00297.x
  31. 31Inoue K, Kitamura J, Yoneda M, Imamura E, Tokinobu H. Hashimoto’s encephalopathy presenting with micrographia as a typical feature of parkinsonism. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2012; 33: 395397. DOI: 10.1007/s10072-011-0750-x
  32. 32Ryan SA, Kennedy C, Harrington HJ. Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting as confusion, dysphasia, and myoclonus. Case reports in medicine. 2012; 2012: 782127. DOI: 10.1155/2012/782127
  33. 33Park J, Kim JG, Park SP, Lee HW. Asymmetric chorea as presenting symptom in Graves’ disease. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2012; 33: 343345. DOI: 10.1007/s10072-011-0679-0
  34. 34Nakavachara P, Suppakrucha M, Likasitwattanakul S. Thyrotoxic periodic paralysis and chorea: two uncommon neuromuscular complications in an adolescent with newly diagnosed Graves disease. Int J Pediatr Endocrinol. 2013; 2013: P145P145. DOI: 10.1186/1687-9856-2013-S1-P145
  35. 35Kaminska A, Kaminski M, Nowaczewska M, Ksiazkiewicz B, Junik R. Chorea, convulsive seizures and cognitive impairment in a patient with autoimmune thyroid disease. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013; 34: 263264. DOI: 10.1007/s10072-012-0990-4
  36. 36Ghoreishi E, Shahidi GA, Rohani M, Nabavi M, Aghaei M, Akhoundi FH. Palatal-Myoclonus as a Presentation of Hashimoto Encephalopathy: an interesting case report. Iranian journal of psychiatry. 2013; 8: 149151.
  37. 37Philip R, Saran S, Gutch M, Gupta K. An unusual presentation of Hashimoto’s encephalopathy. Indian journal of endocrinology and metabolism. 2014; 18: 113115. DOI: 10.4103/2230-8210.126589
  38. 38Saygi S, Ozkale Y, Erol I. Tic disorder probably associated with steroid responsive encephalopathy with autoimmune thyroiditis (SREAT). Indian journal of pediatrics. 2014; 81: 11051107. DOI: 10.1007/s12098-014-1374-y
  39. 39Rozankovic PB, Rozankovic M, Susak I, Vlahovic I, Sporis D. Steroid-responsive autoimmune encephalopathy associated with autoimmune thyroiditis (SREAT) presenting with myoclonus-dystonia syndrome. J Neurol Sci. 2015; 354: 110111. DOI: 10.1016/j.jns.2015.04.021
  40. 40Lee HJ, Jeon K, Lee JY, et al. Ocular flutter and ataxia without cognitive impairment associated with steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT). J Neurol Sci. 2015; 359: 8687. DOI: 10.1016/j.jns.2015.10.037
  41. 41Sharan A, Sengupta S, Mukhopadhyay S, Ghosh B. Hashimoto’s Encephalopathy Presenting with Chorea. The Journal of the Association of Physicians of India. 2015; 63: 8384. DOI: 10.4103/0028-3886.170064
  42. 42Sheetal SK, Mathew R, Peethambaran B. Hashimoto’s encephalopathy as a treatable cause of corticobasal disease. Annals of Indian Academy of Neurology. 2016; 19: 285286. DOI: 10.4103/0972-2327.176859
  43. 43Ramcharan K, Hosein N, Teelucksingh JD, Rampersad F, Teelucksingh S. Prominent Bilateral Hand Tremor in Hashimoto’s Encephalopathy: A Video Demonstration. Tremor Other Hyperkinet Mov (N Y). 2016; 6: 419. DOI: 10.5334/tohm.305
  44. 44Correia I, Marques IB, Ferreira R, Sousa L. Encephalopathy Associated with Autoimmune Thyroid Disease: A Potentially Reversible Condition. Case reports in medicine. 2016; 2016: 9183979. DOI: 10.1155/2016/9183979
  45. 45Kelly DM, Lynch T, Casserly LF. Abdominal tremor in thyrotoxicosis. Neurology. 2017; 89: 14241425. DOI: 10.1212/WNL.0000000000004403
  46. 46Keshavaraj A, Anpalagan J. Reversible Orolingual Dyskinesia: An Unknown Presentation of Hashimoto’s Toxic Encephalopathy. Journal of Case Reports. 2018: 169171. DOI: 10.17659/01.2018.0045
  47. 47Miranda M, Bustamante ML, Campero M, et al. Movement disorders in non-encephalopathic Hashimoto’s thyroiditis. Parkinsonism Relat Disord. 2018; 55: 141142. DOI: 10.1016/j.parkreldis.2018.06.008
  48. 48Mohd Fauzi NA, Abdullah S, Tan AH, Mohd Ramli N, Tan CY, Lim SY. Relapsing encephalopathy with dancing eyes and jerky limbs. Parkinsonism Relat Disord. 2019. DOI: 10.1016/j.parkreldis.2019.02.025
  49. 49Delhasse S, Debove I, Arnold-Kunz G, Ghika JA, Chabwine JN. Erratic movement disorders disclosing Graves’ disease and paralleling thyroid function but not autoantibody levels. The Journal of international medical research. 2019:300060518816873. DOI: 10.1177/0300060518816873
  50. 50Shree R, Madhaw G, Manchanda R, Radhakrishnan D, Kumar N. Steroid responsive catatonia: A case of Hashimoto’s encephalopathy. Annals of Movement Disorders. 2020; 3: 5155. DOI: 10.4103/AOMD.AOMD_32_19
  51. 51Klawans HL, Jr., Shenker DM. Observations on the dopaminergic nature of hyperthyroid chorea. Journal of neural transmission. 1972; 33: 7381. DOI: 10.1007/BF01244729
  52. 52Watanabe T, Onda H. Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis. Pediatric nephrology (Berlin, Germany). 2004; 19: 451453. DOI: 10.1007/s00467-003-1388-6
  53. 53Lai PH, Tien RD, Chang MH, et al. Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR American journal of neuroradiology. 1996; 17: 10571064.
  54. 54Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997; 49: 623626. DOI: 10.1212/WNL.49.2.623
  55. 55Pari E, Rinaldi F, Premi E, et al. A follow-up (1)(8)F-FDG brain PET study in a case of Hashimoto’s encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. J Neurol. 2014; 261: 663667. DOI: 10.1007/s00415-013-7228-0
  56. 56George A, Abdurahman P, James J. Spastic paraparesis, abnormal muscle biopsy and positive antithyroid antibodies. The Journal of the Association of Physicians of India. 2007; 55: 585586.
  57. 57Blanchin S, Coffin C, Viader F, et al. Anti-thyroperoxidase antibodies from patients with Hashimoto’s encephalopathy bind to cerebellar astrocytes. Journal of neuroimmunology. 2007; 192: 1320. DOI: 10.1016/j.jneuroim.2007.08.012
  58. 58Takahashi S, Mitamura R, Itoh Y, Suzuki N, Okuno A. Hashimoto encephalopathy: etiologic considerations. Pediatric neurology. 1994; 11: 328331. DOI: 10.1016/0887-8994(94)90011-6
  59. 59Oide T, Tokuda T, Yazaki M, et al. Anti-neuronal autoantibody in Hashimoto’s encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients. J Neurol Sci. 2004; 217: 712. DOI: 10.1016/j.jns.2003.08.005
  60. 60Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinology and metabolism clinics of North America. 2001; 30: 315337, viii. DOI: 10.1016/S0889-8529(05)70189-4
  61. 61Kirshner HS. Hashimoto’s encephalopathy: a brief review. Current neurology and neuroscience reports. 2014; 14: 476. DOI: 10.1007/s11910-014-0476-2
  62. 62Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S. Diagnostic and therapeutic aspects of Hashimoto’s encephalopathy. J Neurol Sci. 2013; 331: 6771. DOI: 10.1016/j.jns.2013.05.009
  63. 63Cook MK, Malkin M, Karafin MS. The use of plasma exchange in Hashimoto’s encephalopathy: A case report and review of the literature. Journal of clinical apheresis. 2015; 30: 188192. DOI: 10.1002/jca.21353
DOI: https://doi.org/10.5334/tohm.175 | Journal eISSN: 2160-8288
Language: English
Submitted on: May 4, 2020
Accepted on: May 25, 2020
Published on: Jul 8, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Ritwik Ghosh, Subhankar Chatterjee, Souvik Dubey, Alak Pandit, Biman Kanti Ray, Julián Benito-León, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.